IB

Indu Baloni

Active Director Director DIN 08974486
DIN 08974486 First appointment Nov 2020 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Indu Baloni

Data last updated:

Indu Baloni is a Director at Salene Biotech Private Limited (since 2020). The company operates in Electrnoics. Salene Biotech Private Limited reported revenue of ₹50.1 Lakh (FY 2025).

DIN 08974486
Primary Designation Director
Industry Electrnoics
First Appointment 28 Nov 2020
Oldest Company Age 6 yrs
Largest company Salene Biotech Private Limited · ₹50.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Salene Biotech Private Limited U52603CH2020PTC043127
Director28 Nov 20202020₹50.1 Lakh (FY 2025)Active

Board colleagues of Indu Baloni

NameDINCompanyDesignation
Rakesh Chander08818072Salene Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Salene Biotech Private Limited
Premium access

Shareholding and investment profile for Indu Baloni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indu Baloni

Indu Baloni currently holds 1 directorship: Salene Biotech Private Limited (Director, since 28 Nov 2020, revenue ₹50.1 Lakh (FY 2025)).

Indu Baloni was first appointed on 28 Nov 2020 as Director at Salene Biotech Private Limited.

The current boards of Indu Baloni's companies include Rakesh Chander (Salene Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available